Edition:
United States

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329.SS)

600329.SS on Shanghai Stock Exchange

13.27CNY
23 Feb 2018
Change (% chg)

¥0.18 (+1.38%)
Prev Close
¥13.09
Open
¥13.21
Day's High
¥13.42
Day's Low
¥13.08
Volume
1,439,500
Avg. Vol
2,371,645
52-wk High
¥19.98
52-wk Low
¥12.51

Latest Key Developments (Source: Significant Developments)

Tianjin Zhongxin Pharmaceutical says qtrly ‍revenue was down 14​ percent
Monday, 30 Oct 2017 05:25am EDT 

Oct 30 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::Qtrly ‍revenue RMB1.31 billion, down 14​ percent.Qtrly profit, net of tax attributable RMB82 million versus RMB91.6 mln‍​.  Full Article

Tianjin Zhongxin Pharmaceutical Group appoints Li Li Qun as chairman​
Tuesday, 10 Oct 2017 06:40am EDT 

Oct 10 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:‍Resolution passed to appoint Li Li Qun as chairman​.  Full Article

Tianjin Zhongxin Pharmaceutical Group ‍signed investment product agreement with China Bohai Bank
Thursday, 24 Aug 2017 05:52am EDT 

Aug 24 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>-:Signed investment product agreement with China Bohai Bank to invest rmb200 million into capital-protected investment product​.  Full Article

Tianjin Zhongxin Pharma's chairman and general manager resigns due to change in job role
Thursday, 24 Aug 2017 04:57am EDT 

Aug 24 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:Says Chairman and General Manager Wang Zhiqiang resigns due to change in job role.  Full Article

Tianjin Zhongxin Pharmaceutical Group adopts new accounting policy
Monday, 14 Aug 2017 10:38pm EDT 

Aug 15 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:* Says it adopted new accounting policy disclosed by the Ministry of Finance on May 10, regarding subsidy .* Effective June 12.  Full Article

Tianjin Zhongxin Pharmaceutical says qtrly revenue rmb1.51 billion
Monday, 14 Aug 2017 05:10am EDT 

Aug 14 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>::Qtrly revenue rmb1.51 billion versus rmb 1.62 billion.Qtrly profit net of tax attributable to owners of parent rmb142.1 million versus rmb140.6 million.  Full Article

Tianjin Zhongxin Pharma's H1 net profit up 7.3 pct y/y
Monday, 14 Aug 2017 04:49am EDT 

Aug 14 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>:Says H1 net profit up 7.3 percent y/y at 277.5 million yuan ($41.61 million).  Full Article

Tianjin Zhongxin Pharmaceutical Group to pay A shares annual div for FY 2016 on July 14
Thursday, 6 Jul 2017 11:13pm EDT 

July 7 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> ::* Says it will pay cash dividend of 0.15 yuan(before tax)/share for 2016 to shareholders of record on July 13 .* The company's shares will be traded ex-right and ex-dividend on July 14 and the dividend will be paid on July 14 .  Full Article

Tianjin Zhongxin Pharmaceutical group entered into a share transfer agreement with Jiaxing Yun Shi Tai Yu Investment Partnership​
Tuesday, 27 Jun 2017 05:09am EDT 

June 27 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS>-:Entered into a share transfer agreement with Jiaxing Yun Shi Tai Yu Investment Partnership​.‍Company has agreed to sell its entire 20% equity stake in Tianjin Sinobioway Biomedicine Co​.Proposed disposal not expected to have material impact on co's earnings per share for current fy.‍Deal for a cash consideration of rmb47.8 million.  Full Article

Tianjin Zhongxin Pharmaceutical to pay annual cash div as 1.5 yuan per 10 shares for FY 2016
Monday, 3 Apr 2017 01:45am EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd <600329.SS> :Says it plans to pay annual cash dividend as 1.5 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article